UTMD Earnings UTAH MEDICAL PRODUCTS INC
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | 1.66 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.82 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | 3.48 | 2026-03-27 | 10-K |
| FY 2025 | 2025-09-30 | 0.82 | 2026-03-27 | 10-K |
| Q2 2026 | 2025-06-30 | 1.86 | 2026-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.92 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | 3.96 | 2026-03-27 | 10-K |
| FY 2025 | 2024-09-30 | 1.03 | 2026-03-27 | 10-K |
| FY 2025 | 2024-06-30 | 0.98 | 2026-03-27 | 10-K |
| FY 2025 | 2024-03-31 | 1.09 | 2026-03-27 | 10-K |
| FY 2025 | 2023-12-31 | 4.57 | 2026-03-27 | 10-K |
| FY 2025 | 2023-09-30 | 1.08 | 2026-03-27 | 10-K |
| FY 2025 | 2023-06-30 | 1.15 | 2026-03-27 | 10-K |
| FY 2025 | 2023-03-31 | 1.16 | 2026-03-27 | 10-K |
| FY 2024 | 2022-12-31 | 4.52 | 2025-03-26 | 10-K |
| FY 2024 | 2022-09-30 | 1.18 | 2025-03-26 | 10-K |
| FY 2024 | 2022-06-30 | 1.12 | 2025-03-26 | 10-K |
| FY 2024 | 2022-03-31 | 0.96 | 2025-03-26 | 10-K |
| FY 2023 | 2021-12-31 | 4.04 | 2024-03-26 | 10-K |
| FY 2023 | 2021-09-30 | 1.15 | 2024-03-26 | 10-K |
| FY 2023 | 2021-06-30 | 0.94 | 2024-03-26 | 10-K |
| FY 2023 | 2021-03-31 | 0.83 | 2024-03-26 | 10-K |
| FY 2022 | 2020-12-31 | 2.94 | 2023-03-27 | 10-K |
| FY 2022 | 2020-09-30 | 0.80 | 2023-03-27 | 10-K |
| FY 2022 | 2020-06-30 | 0.36 | 2023-03-27 | 10-K |
| FY 2022 | 2020-03-31 | 0.84 | 2023-03-27 | 10-K |
| FY 2021 | 2019-12-31 | 3.94 | 2022-03-25 | 10-K |
| FY 2021 | 2019-09-30 | 0.99 | 2022-03-25 | 10-K |
| FY 2021 | 2019-06-30 | 0.94 | 2022-03-25 | 10-K |
| FY 2021 | 2019-03-31 | 0.84 | 2022-03-25 | 10-K |
| FY 2020 | 2018-12-31 | 4.95 | 2021-03-26 | 10-K |
| FY 2020 | 2018-09-30 | 1.80 | 2021-03-26 | 10-K |
| FY 2020 | 2018-06-30 | 1.15 | 2021-03-26 | 10-K |
| FY 2020 | 2018-03-31 | 1.09 | 2021-03-26 | 10-K |
| FY 2019 | 2017-12-31 | 2.28 | 2020-03-16 | 10-K |
| FY 2019 | 2017-09-30 | 0.97 | 2020-03-16 | 10-K |
| FY 2019 | 2017-06-30 | 1.04 | 2020-03-16 | 10-K |
| FY 2019 | 2017-03-31 | 0.95 | 2020-03-16 | 10-K |
| FY 2018 | 2016-12-31 | 3.22 | 2019-03-14 | 10-K |
| Q3 2017 | 2016-09-30 | 2.49 | 2017-11-07 | 10-Q |
| Q2 2017 | 2016-06-30 | 1.72 | 2017-08-03 | 10-Q |
| Q1 2017 | 2016-03-31 | 0.85 | 2017-05-05 | 10-Q |
| FY 2017 | 2015-12-31 | 3.14 | 2018-03-06 | 10-K |
| Q3 2016 | 2015-09-30 | 2.29 | 2016-11-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.